Reflecting on the Year of Data Acceleration: A Network update by Dr. André Veillette
Dr. André Veillette, Executive Director of the Marathon of Hope Cancer Centres Network, provides an update on the Year of Data Acceleration.
Dear colleagues,
One year ago, we announced that our Network would be embarking on the Year of Data Acceleration. Today, I want to provide an exciting update on what we were able to collectively achieve this year by working together towards this common goal.
The Early Days
In Feb. 2019, the Federal Government announced that it would help fund the Network, but it wasn't until June 2021, when the Terry Fox Research Institute signed a Contribution Agreement with Health Canada, that work officially started. At that point, the Network was made up of four founding members – BC Cancer, the Princess Margaret Cancer Centre, the Goodman Cancer Institute at McGill University and the Centre de recherche du Centre hospitalier de l’Université de Montréal (CR-CHUM) – who came together under the leadership of the Terry Fox Research Institute.
Between June 2021 and December 2022, Network operations ramped up. We set up a governance structure and new staff joined the team. Working groups were formed or re-ignited, and standards for the generation, curation and sharing of data were created. Cohorts that would contribute data to the MOHCCN Gold Cohort were identified by regional consortia in Ontario, Quebec and British Columbia, which, anchored by our founding members, had begun to grow and mature as new members joined the Network. In December 2021, institutions in the Prairie provinces came together to form the Prairie Cancer Consortium. By January of 2023, the Atlantic Cancer Consortium, our final regional consortium, joined the Network, completing our coast-to-coast expansion.
At that point, 888 full genomic profiles had been sequenced for the Gold Cohort. Things were starting to pick up steam, but we were behind schedule with our cases and our expenditures. We had to ramp up the pace of data generation, which led us to reach out to each Consortium to better understand the particularities of each region and the bottlenecks that were slowing down the accrual of cases. This led to important changes that would make it easier for sites to generate cases for the Network.
The Year of Data Acceleration
Our data acceleration strategy was put in motion that January, and by April we were excited to announce that the fiscal year that runs from April 1, 2023, to March 31, 2024, would be the Year of Data Acceleration.
Building on new processes and lessons learned over the first few years of the project, the data started flowing and our Network began to grow more quickly. New members joined, new programs were launched and new cohorts were supported. We launched a dashboard to track our progress on our website and removed administrative bottlenecks that were affecting data generation. This helped make the Year of Data Acceleration a resounding success.
From April 2023 – March 2024:
MOHCCN Gold Cohort cases with full genomic profiles almost doubled from 2,547 to 4,287 (remember we were only at 888 that January!)
Cases with full clinical data went from 0 to 1095
Institutional memberships increased from 24 to 34
Gold Cohort-contributing cohorts increased from 62 to 99
Total Research Project Grant Agreements signed increased from 19 at the end of fiscal 2023 to 117 at the end of fiscal year 2024
10 policies and guidelines were released or updated
20 Pan-Canadian projects were awarded
12 new early-career researchers were named recipients of our two early-career grant programs
The Patient Working Group was launched to ensure patients helped shape Network operations
The growth of the Network over the last year has been incredible, and none of it would have been possible without support from you, the over 600 patients, researchers, clinicians, administrators and data scientists who make up this growing Network.
We are extremely proud of our collective accomplishment over the last year, and yet, we know there’s still a lot of work to do…
Introducing the Year of Capacity Building
As we enter fiscal year 2025, our goal is to continue growing the Network, so it better represents all Canadians. To achieve this, today we are announcing the launch of the Year of Capacity Building. This new strategy will see us create new systems to accelerate the ingestion of clinical data to the Network, while focusing on expanding our reach from coast-to-coast-to-coast by adding new members from smaller centres, strengthening our regional consortia, launching new funding programs and creating new strategies to reach underserved and underrepresented communities. This will help us improve capacity across the country for the accrual, ingestion and sharing of Gold Cohort data, while ensuring this resource reflects the diversity of our entire nation, so that precision medicine can benefit us all.
Back in 1980, Terry Fox invited every Canadian to join his Marathon of Hope. True to Terry’s spirit, our goal for the coming fiscal year is to start paving the way for more Canadians to join our Marathon of Hope Cancer Centres Network.
Sincerely,
Dr. André Veillette,
Executive Director, MOHCCN
Latest News
New funding opportunity
The MOHCCN and the Terry Fox Research Institute have launched the TFRI-MOHCCN Technology Development Awards to develop additional profiling technologies that would generate data compatible with precision oncology and could be applied to a section of the MOHCCN Gold Cohort. Read more and apply here.
New Pan-Canadian Projects announced
The second group of projects that will receive funding through the Pan-Canadian Projects Program was announced in March. This includes a project tackling rare gynecological cancers, a project tackling rare breast cancers, an ovarian cancer team and a new clinical trial for patients with pancreatic cancers.
More projects will be announced in the coming months.
Explainers
Since its inception, our Network has united researchers, clinicians, patients, donors and administrators from institutions across Canada under a single vision: The Roadmap to Cure Cancer. Here are 7 ways this vision will benefit Canadians.
What is the MOHCCN Gold Cohort anyway? This explainer breaks down why we’re creating the biggest and most complete cancer case resource in Canada to advance precision medicine for cancer.
Team Canada of Cancer Research News
The Terry Fox Research Institute and the Marathon of Hope Cancer Centres Network congratulate Dr. Lillian Siu on being elected president of the American Association for Cancer Research
Starting in March, the Network will be introducing members of the Team Canada of Cancer Research. The first interview in this series is with Dr. Hanne Ostergaard, director of the Cancer Research Institute of Northern Alberta.
Network voices
Patient story. Patricia Turnbull has been "dealt a bad hand in the cancer department." But even though she's been diagnosed with multiple cancers over the past 17 years, you won't hear this MOHCCN Patient Working Group member complain. Instead, she's grateful that precision medicine has helped detect her cancers earlier and envisions a day when all cancer patients in Canada can benefit from it the way she has.
Expert opinion. Dr. Ana Nikolic, a neuropathologist at the University of Calgary and holder of an MOHCCN Clinician-Scientist Award, discusses why investing in early-career clinician-scientists is investing in the future of healthcare in Canada.
Patient story. Precision medicine is saving her life, but more needs to be done for it to help others, argues Christine Wu, a member of our Patient Working Group based in Manitoba.
Expert opinion. Adrian Thorogood, TFRI’s Data Governance Manager, explains how the Marathon of Hope Cancer Centres Network is supporting responsible data sharing to advance precision oncology.
Events
Leadership and researchers from the Princess Margaret Cancer Consortium presented updates to Network members as part of the first event of the second season of the MOHCCN Seminar Series. You can re-watch their presentations here.
The next event of the MOHCCN Seminar Series will feature updates from leadership and researchers at the Marathon of Hope – Québec consortium. The event will be held on April 25 at 2pm ET. You can register to attend here.
"The data started flowing and our Network began to grow more quickly. New members joined, new programs were launched and new cohorts were supported. This helped make the Year of Data Acceleration a resounding success. "
Related Team Members
-
Isabel
Managing Director
Serrano -
André
Executive Director
Veillette
-
Regional Consortia
BC Cancer Consortium
- British Columbia
The overall vision of the BC Cancer Consortium is to further strengthen our province-wide research capabilities and partnerships, to improve our ability to support innovation in clinical care, and fir...Read more -
Regional Consortia
Marathon of Hope - Québec
- Québec
The Marathon of Hope – Québec (MOH-Q) brings together leading scientists and clinicians from hospitals and research centres including the Research Institute of the McGill University Health Centre (RI-...Read more -
Regional Consortia
Princess Margaret Cancer Consortium
- Ontario
The Princess Margaret Cancer Consortium coalesces the expertise and efforts of clinicians, pathologists, software developers and data and translational scientists to help accelerate precision medicine...Read more -
Regional Consortia
Prairie Cancer Consortium
- Alberta
- Manitoba
- Saskatchewan
The overall vision of the PR2C is to create a collaborative, inclusive, equitable, and sustainable multiprovincial initiative that works towards developing new treatment strategies for patients facing...Read more -
Regional Consortia
Atlantic Cancer Consortium
- Prince Edward Island
- New Brunswick
- Newfoundland and Labrador
- Nova Scotia
We have rallied our region’s leading cancer researchers, institutions and care facilities to unite around this vision to enhance inter-institutional and inter-provincial cancer research collaboration,...Read more
Related News
-
PM2 CAN-IMPACT-IO a national immunotherapy biospecimen collection study has now opened
PM2 CAN-IMPACT-IO is a unique national initiative to measure, predict and assess cancer treatment outcomes in patients who have been treated with immunotherapy. Patients on CCTG clinical trials who co... -
Our Network reaches new heights! A letter from Dr. André Veillette
Dr. André Veillette, Executive Director of the MOHCCN, provides an update on the exciting achievement from across our Network. -
Network names four outstanding early-career clinician-scientists as recipients of its 2024 MOHCCN Clinician-Scientist Awards
Four promising, early-career clinician-scientists from Alberta, Ontario and Quebec have been named recipients of the 2024 Clinician-Scientist Awards, funded by the Marathon of Hope Cancer Centres Netw... -
Network names 10 early-career data scientists as recipients of its 2024 Health Informatics & Data Science Awards
Each will receive $40,000 from the Network over the next year to be matched by their host institutions for a total of $80,000 to support groundbreaking research in precision oncology.